- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00018720
Regulation of Sterol Homeostasis
The purpose of this study is to determine how people with high triglycerides metabolize and absorb bile acids, compounds made in the body from cholesterol.
This project has two objectives: A) To define the mechanism of impaired bile acid absorption in hypertriglyceridemia (specifically we will determine if the active or passive component of absorption is abnormal) and B) to determine the contribution of an alternative pathway of bile acid synthesis which begins with 27-hydroxylation of cholesterol. Because 27-hydroxylase is present in endothelial cells as well as liver, this pathway may play a role in removal of cholesterol from incipient atherosclerotic plaque.
Study Overview
Status
Conditions
Study Type
Contacts and Locations
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55417
- VA Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
Collaborators and Investigators
Investigators
- Norman Javitt, M.D.
- Alan Hofmann, M.D.
- Loren Zech, M.D.
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- GAST-026-95F
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertriglyceridemia
-
Ionis Pharmaceuticals, Inc.RecruitingHypertriglyceridemia | Severe HypertriglyceridemiaUnited States
-
Eli Lilly and CompanyRecruitingSevere HypertriglyceridemiaUnited States, China, Japan, Canada
-
Arrowhead PharmaceuticalsCompletedSevere HypertriglyceridemiaUnited States, Australia, Canada, Germany, Hungary, Netherlands, New Zealand, Poland
-
AstraZenecaCompletedSevere HypertriglyceridemiaUnited States, Hungary, India, Russian Federation, Denmark, Ukraine, Netherlands
-
AstraZenecaRadiant ResearchCompletedSevere HypertriglyceridemiaUnited States
-
Trygg Pharma, Inc.UnknownSevere HypertriglyceridemiaUnited States
-
SUNHO(China)BioPharmaceutical CO., Ltd.Not yet recruitingHealthy Subjects | Hyperlipidemia, HypertriglyceridemiaChina
-
Ionis Pharmaceuticals, Inc.CompletedSevere HypertriglyceridemiaFinland, United States, France, Israel, Netherlands, Denmark, Spain, Australia, United Kingdom, Germany, Italy, Canada, Czechia, Hungary, Bulgaria, New Zealand, Sweden, South Africa, Poland, Norway, Portugal, Slovakia, Turkey (Türkiye)
-
Arrowhead PharmaceuticalsActive, not recruitingSevere HypertriglyceridemiaUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Hungary, Italy, Poland, Romania, Slovakia, Spain, United Kingdom
-
89bio, Inc.Active, not recruitingSevere HypertriglyceridemiaUnited States, Puerto Rico, Hungary, Poland, Argentina, Austria, Belgium, Bulgaria, Canada, Chile, Czechia, France, Georgia, Germany, India, Italy, Latvia, Mexico, Spain, United Kingdom